Last reviewed · How we verify
NCT04573829: PSYDOMA
PsyDoMa : Non-drug Approaches at Home for Alzheimer's Patients With Psycho-behavioural Disorders
NA trial testing Home visit in Behavioral Disorder in 40 participants. Completed in 19 September 2022.
31 March 2022
Quick facts
| Lead sponsor | Centre Hospitalier Universitaire de Nice |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | health services research |
| Enrollment | 40 |
| Start date | 14 January 2021 |
| Primary completion | 31 March 2022 |
| Estimated completion | 19 September 2022 |
| Sites | 1 location across France |
Drugs / interventions tested
- Home visit
Conditions studied
- Behavioral Disorder — all drugs for Behavioral Disorder →
Sponsor
Centre Hospitalier Universitaire de Nice
Who can join
65 and older, any sex, with Behavioral Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Recruitment is carried out directly at the geriatric unit of the CIMIEZ University Hospital Center by geriatric doctors during day consultation or in short stay unit. The doctor wil select carer -patient couples more likely to take part in the study. The investigator will give them an informative leaflet and they will have to sign the consent form. A diagnosis is made by the investigator. The patient will first have to undergo a neurocognitive assessment carried out at the Cimiez Hospital (test for the evaluation of a cognitive deficit) by a psychologist. The non-drug approaches presented will be carried out directly at the participant's home with the help of the carer for therapeutic purposes. The therapeutic objectives and the choice of approaches are specified within the Personalised Accompaniment Project (PAP). The carer, if he or she wishes, participates in the sessions in order to reproduce the behaviours implemented by the psychologist. Different workshops will be offered : Cooking, Art Therapy, Games, Multi-sensory, Soft Gymnastic, Relaxation, Music and Reminisence. Patients will received three visits per week during six months. The carer will receive one visit per week for six months.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04573829
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Home visit
Trials testing the same drug.
- NCT05168605 — Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions · NA · recruiting
- NCT04376736 — Home Visits for Patients at Risk for Appointment No-shows · NA · withdrawn
- NCT03178513 — Post-Acute Physician Home Visit Program · NA · completed
- NCT02737839 — Adaptation of the STEPPING ON Fall Prevention Program for Older Adults Receiving Cancer Therapy · NA · completed
Other recruiting trials for Behavioral Disorder
Currently open trials in the same condition.
- NCT06852443 — Troubled-Desire & Therapeutic Chat for Reduction of CSAM Use (TD-CHAT) · NA · recruiting
- NCT04236882 — Sleep and Physical Activity Intervention for Increasing Physical Activity in Overweight or Obese and Sedentary African A · NA · active not recruiting
Other Centre Hospitalier Universitaire de Nice trials
Trials by the same sponsor.
- NCT05897996 — Percutaneous Anastomosis Creation for Hemodialysis Access · NA · withdrawn
- NCT07499869 — INNOVATIVE BENEFITS OF A 4D VIRTUAL SIMULATOR · NA · not yet recruiting
- NCT07492251 — Upadacitinib in Adult Patients With Erosive Mucosal Lichen Planus and Lichen Planopilaris: a Prospective Multicenter Ran · Phase 2 · not yet recruiting
- NCT07511608 — Development of a New Technique for Quantifying Mitochondrial DNA in Single Muscle Fibers · NA · not yet recruiting
- NCT07582406 — Codesign, Physical Activity, and Seniors · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04573829 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Universitaire de Nice
- Last refreshed: 7 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04573829.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing